AbCellera Biologics

Biotechnology company

Stránky společnosti

Ticker

ABCL.NASDAQ

Trh

Rok založení

2012

Uzávěrka

2/10/2021

Datum IPO

12/10/2020

Cena umístění

$20

Ziskovost

125.8%

O společnosti

Total Funding

$371.2M

AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics

Number of employees

101-250

Headquarters

Vancouver, British Columbia, Canada